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HIV-1 seroconversion incidence following pregnancy and delivery 
among women seronegative at recruitment in Harare, Zimbabwe
*MT MBIZVO, *J KASULE, *K MAHOMED, **K NATHOO
Abstract
Objective: To estimate the incidence of HIV seroconversion among women following pregnancy and' 
delivery.
Design: A prospective cohort of women who were HIV negative at recruitment on first antenatal care visit. 
Materials and Methods: Pregnant women were invited to undergo voluntary confidential HIV counselling 
and blood draw for HIV testing during the first antenatal care visit as part of a prospective study of mother- 
to-child transmission of HIV-1. Repeat tests were conducted at delivery, six weeks post partum and at three 
monthly intervals until 24 months or on termination due to subsequent pregnancy, death or loss to follow up. 
Logistic regression modelling was used to determine independent predictors of HIV seroconversion. 
Results: Among 372 HIV negative pregnant women who were enrolled, 66 seroconverted during follow up, 
resulting in a sero-incidence of 4.8 per 100 person years (95% confidence interval [Cl], 3.1 to 6.5). Women 
who did not seroconvert during the time of pregnancy or follow up were significantly more likely to have used 
a condom with their partners (OR = 0.68,95% Cl = 0.47 to 0.99). Women aged 17 years and below had the 
highest seroconversion incidence (6.25%) followed by those aged 18 to 19 years (5.42%). Women who 
seroconverted and those who were HIV positive at recruitment were more likely to be married. Lack of 
education by the partner of a pregnant woman constituted a significant risk factor for HIV seroconversion (OR 
= 2.8; 95% Cl = 1.1 to ll.0 ).
Conclusions: There is a high HIV seroconversion incidence among women during pregnancy and following 
delivery, especially those aged 19 years and below. Being married does not protect the women from the risk 
of HIV seroconversion. Strategies for HIV prevention should target pregnant women and their partners.
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Introduction
Whereas HIV infection rates have plateaued in most 
developed countries, sub-Saharan Africa continues to 
experience a high infection rate from heterosexual 
transmission. It is estimated that 70% of the world’s 33
million infected people live in Africa.1 The high prevalence 
constitutes a majorpublic health problem which is likely to 
continue to draw on scarce health resources in the region.
In 1999, it was estimated that 600 000 children worldwide 
became infected with HIV through mother-to-child 
transmission (MTCT).2 Over 90% of such infections occur
*D e p a r tm e n t o f  O b s te tr ic s  a n d  G y n a e c o lo g y C o rre s p o n d e n c e  to:
U n iv e r s ity  o f  Z im b a b w e  M e d ic a l S c h o o l P ro fe s so r  M ic h a e l T  M b izv o
i,:;]'D e p a r tm e n t o f  P a e d ia tr ic s  M e d ic a l S c h o o l D e p a r tm e n t o f  R e p r o d u c tiv e  H e a lth  a n d  R esea rch
P  O  B o x  A 1 7 8 W o rld  H e a lth  O r g a n iz a tio n
A v o n d a le C H 2 1 1  G en ev a  2 7
H a r a r e S w itz e r la n d
Z im b a b w e E -m a il  m b izv o m @ w h o .c h
F a x :  4 1 -2 2 -7 9 1 -4 1 7 1
T el: 4 1 -2 2 -7 9 1 -4 2 4 5
CentAfr J Med 2001;47(5) 115
in the resource-poor world, where a median survival of 
four to five years is found among HIV infected children.3 
The majority of mothers in these developing countries 
(over 95%), breastfeed their children4 and the potential for 
MTCT is a recent cause for concern among policy-makers, 
programme managers, service providers and researchers.
Transmission of HIV can occur in-utero, during labour 
and delivery or in the post partum  period through breast 
milk. Factors influencing the risk of transmission from 
mother to child include the viral load,'genotype and 
phenotype, strain diversity, the immunological status of 
the mother, duration of ruptured membranes* mode of 
delivery and breastfeeding. The risk of HIV infection to the 
child through breastfeeding could be increased in instances 
where the mother is infected during pregnancy or during 
the course of breastfeeding. .
In Zimbabwe, whereas the seroprevalence of HIV in 
pregnant wofnen of up to 30.2% has been documented,5 
there is no data published on seroconversion among women 
during pregnancy or following delivery. Amongst male 
factory workers, a seroconversion incidence of 2,96% 
(95%CI = 2.47 to3,52) was reported in Harare.6 As MTCT 
of HIV is an increasingly important public health problem, 
the present study sought to determine, among other things, 
risk factors associated with HIV seroconversion during 
pregnancy and following delivery and its incidence. Such 
data should help to deal effectively and rationally with 
counselling and prevention of paediatric HIV infection.
Materials and Methods
Approval for the study was obtained from the Medical 
Research Council of Zimbabwe, the Medical Superitendent 
of Harare Central Hospital and the Director of Harare City 
Medical Services. HIV seropositive and seronegative 
mothers were identified in early pregnancy following 
voluntary testing of HIV and counselling in four antenatal 
care clinics of Harare, Zimbabwe. The pregnant women 
were informed about the optional HIV testing and 
participation in the project according to guidelines given 
by the World Health Organization’s Special Programme 
for Research, Research Training and Development (WHO/ 
HRP) which supported the study from 1991 to 1995. 
Women were invited to participate at their first antenatal 
care visit, during which an interview solicited data on age, 
parity and area of residence and other socio-demographic 
characteristics in order to get baseline data on the population 
under study. 1
Women testing HIV ELISA positive according to two 
tests on different blood samples (EIA product 96040, 
96043, 6055 Cambridge Biosciences, Ireland) or Western 
Blot confirmation (product 80486, Cambridge Biosciences 
or Ancoscreen, Ireland) of discrepant ELISA results, were 
invited to participate as index subjects. For each enrolled 
HIV positive woman, an HIV negative pregnant woman in 
the same five year (quinquennial <20, 20 to 24, 35 to 
29 . . . )  age interval was selected at random and invited to
serve as a referent or comparison subject. This resulted in 
a cohort of HIV positive and negative women which was 
1:1 distributed within each age category.
During pregnancy and follow up, medical examination 
was conducted on both women who had tested HIV positive 
and those testing HIV negative at enrolment.
All women were interviewed at recruitment and 
underwent a physical examination following blood 
collection at baseline, 32 and 36 weeks gestation. Further 
clinical data and blood samples were collected for both 
mothers and their infants at delivery, at six weeks post 
partum  and at three monthly intervals thereafter, until 24 
months or on termination due to subsequent pregnancy, 
death or loss to follow up.
All data were entered in duplicate in precoded forms and 
checked for computerized data entry. The main study 
endpoints discussed in this paper were conversion to HIV 
seropositive status . b y ‘women Testing negative at 
recruitment, and associated factors. Logistic, regression 
analysis was used to adjust fot confounding factors and to 
; elucidate the independent factors associated with HIV 
seroconversion, including the relative importance of 
different risk factors.
Results
In the cohort of 758 women followed up, 386 were HIV 
positive and 372 were seronegative. Of the. 372 HIV 
negative women, 66 seroconverted during follow up, 
yielding an overall HIV seroconversion incidence o f 4.8 
' per 100 person years (95% Cl = 3.1 to 6.5) .Table I outlines 
the HIV seroconversion incidence of the women during 
followup.
Table I: HIV seroconversion incidence at delivery and post 
delivery follow up intervals among women negative at 
enrolment.
P re g n a n c y  In te rv a l S e ro c o n v e rs io n  (n )
H IV  in c id e n c e  p e r  100  
p e rs o n  y e a rs
U p  to  delivery 16 4 .3 2
6  m onths a fte r delivery 23 4 .4 4
7 -1 2  m onths 11 5 .2 4
1 3 -2 4  m onths 16 5 .8 0
O verall incidence 6 6 4 .8 0
The women aged 17 years and below had the highest 
seroconversion incidence (6.25 %) followed by those in the 
18 to 19 year age group (5.42%). The HIV seroconversion 
incidence among the women distributed by age is shown in 
Table II.
Regarding the socio-demographic status of the women, 
the majority of women who seroconverted (93.9%) and 
those testing negative at recruitment (98.4%), were married. 
Among the 386 HIV positive women at recruitment, 94.3% 
reported that they were married. Being single, separated or 
divorced did not constitute a risk factor for HIV 
seroconversion among the women, albeit, their proportion
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Table II: HIV seroconversion incidence distributed by age 
among women negative at enrolment.
Age Group Seroconvesion (n) HIV incidence per
(Years) N % 100 person years
O ve ra ll 6 6 10 0 4 .8 0
s 1 7 5 7 .6 6 .2 5
1 8 -1 9 7 1 0 .6 5 .4 2
20 -2 1 10 15 .2 4 .8 8
2 2 -2 3 8 12.1 4 .4 7
2 4 -2 5 10 1 5 .2 4.11
2 6 -2 7 5 7 .6 3 .7 6
2 8 -2 9 6 9.1 3 .5 3
3 0 -3 4 5 7 .6 3.21
3 5 -3 9 1 1.5 2 :7
2 4 0 1 1.5 2 .3 8
was small. Use of condoms during the time of pregnancy 
and follow up conferred significant independent protection 
(in multivariate analysis) against HIV seroconversion (OR
0.68, 95% Cl = 0.47 to 0.99).
The largest proportion of women in all the groups were 
educated to secondary level or above. Lack of education or 
its level did not constitute a risk factor for HIV 
seroconversion (odds ratio [OR] = 1.2; 95% Cl = 0.6 to 
2.3). Seventy four percent of women in the seroconversion. 
and 78% in the seronegative groups had education up to 
secondary level or above, arid in their partners it was 74.2% 
and 79% respectively. Lack of education in the partners of 
pregnant women constituted a significant risk factor (OR 
= 2.8; 95% Cl = 1.1 to 11.0) for HIV seroconversion. 
Occupation , of self and partner did not constitute a risk 
factor for HIV seroconversion.
Medical factors during fo llow  up which were 
independently associated with the likelihood of 
seroconversion were: reported urinary tract infection; recent 
upper respiratory tract infection (URTI) and history of 
unexplained diarrhoea, as shown in Table III.
Table III: Multivariate analysis of independent risk factors 
of HIVseroconversion.
Risk Factors Odds ratio (95%CI) p value
U rin ary  tract in fection 0 .6 3  (0 .4 -0 .9 9 ) 0 .0 4
R ec u rren t U R T I 0 .4 6  (0 .2 2  -0 .9 5 ) 0 .0 3
U n ex p la in e d  d ia rrh o e a 0 .21  (0 .0 5 -0 .9 9 ) 0 .0 4
Medical conditions were similarly distributed and, 
although present, they were not significantly high during 
pregnancy and follow up in the women who seroconverted, 
e.g. groin lymph glands (OR = 0.45; 95% Cl = 0.8 tol.8), 
axilla lymph glands (OR = 2.2; 95% Cl = 0.8 to 6.4), 
vaginal candidiasis (OR = 0.78; 95% Cl = 0.01 to 27.7), 
oral ulceration (OR = 0.7; 95% Cl = 0.02 to 18.2) and oral 
thrush (OR = 1.4; 95% Cl = 0.25 to 7.45).
Discussion
The present findings demonstrate a high risk of HIV 
acquisition by women during and following pregnancy.
The HIV seroconversion incidence of 4.8 % per year 
reported is higher than that of 2.9% reported among male 
factory workers in Harare7 during the study period. 
(However, the prevalence of HIV in both groups was 
comparable, being 18.0 % in pregnant women8 and 19.1% 
in male factory workers9). Independent risk factors for 
seroconversion among men in the factory worker study 
were history of a genital ulcer, number of sexual partners 
and being married but residing separately from the wife. In 
the present study, the majority of the women were married 
and there were no behavioural independent risk factors for 
seroconversion.
The findings point to the need for the promotion of 
strategies for HIV prevention among pregnant women and 
those that target their male partners. Amost likely scenario 
is that there is sexual abstinence during, pregnancy and 
following delivery by a large proportion of married women, 
during which their male partners are exposed to the risk of 
HIV infection through other relationships. The HIV sero- 
incidence in this group of women, which is nearly double 
that of male factory workers, makes it an important target 
group for innovative HIV prevention strategies. Their HIV 
infection has prognostic significance to both the mothers • 
themselves and their infants who are likely to get infected 
through breastfeeding. The postpartum  period might be a 
high risk and vulnerable period for the acquisition of HIV 
by women because of mucosal frailty and hormonal changes 
during this time. A  population-based sero-incidence study 
among women in the reproductive ages in Kigali, Rwanda,10 
established a sero-incidence density of 3.5 per 100 women 
years over a three year period, with the highest incidence 
of 7.6 per 100 women years during the first six months post 
partum  highlighting also the vulnerability of this group of 
women.
Approaches which can be considered for HIV prevention 
in this group include the promotion of mutual abstinence if 
it is considered acceptable or necessary for the woman to 
abstain, use of condoms if engaged in other relationships 
and engaging in other safe sex practices, among male 
partners of women presenting for antenatal care.
In recognition of their vulnerability, women in 
commercial sex work have been targeted by many AIDS 
prevention programmes. Such programmes raise awareness 
of HIV and enable some women to protect themselves 
through condom use or abstinence from sex. However, 
such programmes have little impact on the vulnerability of 
women who are not traditionally considered at risk of HIV, 
such as pregnant women, especially when they are married.
The present findings demonstrate that pregnancy is one 
of the major circumstances during or following which 
women are likely to acquire HIV infection. Thus pregnancy 
could serve as an entry point for positive male involvement 
in reproductive health promotion. Policy-makers and 
reproductive health programme managers are challenged 
to develop strategies which integrate male partners of 
pregnant women into HIV prevention programmes. Such 
targeted programmes could include information, education
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and communication (IEC) on family planning choices, 
possible consequences of sexually transmitted infections 
(STI) on pregnancy outcome, such as syphilis to the infant 
and the risk of HIV to father, mother and infant. Although 
men are known to be concerned with the well being of their 
partners during pregnancy, they are particularly sensitive 
' to the need to protect their offspring from preventable 
adverse health outcomes. Thus the antenatal care period 
could present a window of opportunity for reaching men 
with information aimed at having them identify with, and 
relate to women’s reproductive health needs.
The HIV prevalence in pregnant women in the same 
clinical setting in Harare showed an increase from 18% in 
1990s to 30.4% in 1995.5 A study conducted in 1999,11 
established that the prevalence had plateaued with a 
seroprevalence of 31.1% detected in the same setting. 
These data suggest a high HIV infection rate in the sexually 
. active urban population of Zimbabwe. More effective use 
of clinical care settings to promote HIV prevention may 
help slow the population spread of HIV.
Independent risk factors for seroconversion among men 
in the factory worker study were history of a genital ulcer, 
number of sexual partners and being married but residing 
separately from one’s wife. Thus, health education 
campaigns should address factors associated with the 
continued acquisition of HIV in these vulnerable 
populations.
Information about the timing of HIV-1 transmission 
from mother to child through breastfeeding is still sparse. 
Women who seroconvert during pregnancy and following 
delivery could contribute, to a significant degree, to child 
seroconversion during the breastfeeding period, thereby 
contributing to high infant mortality attributable to HIV. 
Increases in infant mortality due to HIV infection continue 
to reverse many of the gains in child survival achieved in 
recent decades through the expanded immunization 
programme (EPI). The present findings underscore the 
need to broaden approaches towards HIV prevention and 
to respond to the health needs of women who traditionally 
may not have been considered at risk for HIV infection.
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